Search Results - "Akehi, Masaru"
-
1
Novel single‐chain variant of antibody against mesothelin established by phage library
Published in Cancer science (01-09-2019)“…Mesothelin (MSLN) shows increased expression in various cancer cells. For clinical application of antibodies as a positron emission tomography (PET) imaging…”
Get full text
Journal Article -
2
Fluorine-18 (18F)-labeled retinoid x receptor (RXR) partial agonist whose tissue transferability is affected by other RXR ligands
Published in Bioorganic & medicinal chemistry (15-07-2019)“…[Display omitted] Bexarotene (1), a retinoid X receptor (RXR) agonist approved for the treatment of cutaneous T cell lymphoma (CTCL), was reported to migrate…”
Get full text
Journal Article -
3
Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect
Published in Cells (Basel, Switzerland) (01-10-2022)“…BNCT is a non-invasive cancer therapy that allows for cancer cell death without harming adjacent cells. However, the application is limited, owing to the…”
Get full text
Journal Article -
4
In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
Published in Frontiers in cardiovascular medicine (07-09-2023)“…Introduction Transplantation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a promising treatment for heart failure. Information…”
Get full text
Journal Article -
5
Synthesis of 11C‑Labeled RXR Partial Agonist 1‑[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [11C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof
Published in Journal of medicinal chemistry (24-08-2017)“…The retinoid X receptor (RXR) partial agonist 1-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic acid (1; CBt-PMN,…”
Get full text
Journal Article -
6
A Novel 89Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): “Lactosome” Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy
Published in Life (Basel, Switzerland) (18-02-2021)“…“Theranostics,” a new concept of medical advances featuring a fusion of therapeutic and diagnostic systems, provides promising prospects in personalized…”
Get full text
Journal Article -
7
Kinetic Resolution of Secondary Alcohols by Chiral DMAP Derivatives Prepared by the Ugi Multicomponent Reaction
Published in Heterocycles (2013)Get full text
Journal Article -
8
Positron Emission Tomography to Elucidate Pharmacokinetic Differences of Regioisomeric Retinoid X Receptor Agonists
Published in ACS medicinal chemistry letters (12-03-2015)“…RXR partial agonist NEt-4IB (2a, 6-[ethyl-(4-isobutoxy-3-isopropylphenyl)amino]pyridine-3-carboxylic acid: EC50 = 169 nM, E max = 55%) showed a blood…”
Get full text
Journal Article -
9
Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/ lpr Lupus-Prone Mice
Published in Molecular therapy. Methods & clinical development (15-09-2017)“…We evaluated the efficacy of a neutralizing anti-high mobility group box 1 (HMGB1) monoclonal antibody in MRL/ lupus-prone mice. The anti-HMGB1 monoclonal…”
Get full text
Journal Article -
10
The Function of β2-glycoprotein I in Angiogenesis and Its in Vivo Distribution in Tumor Xenografts
Published in Acta medica Okayama (2016)“…Intact β2-glycoprotein I (iβ2GPI) is a glycoprotein that regulates coagulation and fibrinolysis. Nicked β2GPI (nβ2GPI) possesses an angiogenic property at a…”
Get full text
Journal Article -
11
Chiral 1-(1,3-dithian-2-yl) prop-2-en-1-ols: new scaffolds for enantiopure α-hydroxyaldehydes
Published in Tetrahedron (16-09-2015)“…We have demonstrated that chiral 1-(1,3-dithian-2-yl)prop-2-en-1-ols as new scaffolds, obtained by enzyme-catalyzed kinetic resolution, undergo Suzuki-Miyaura…”
Get full text
Journal Article -
12
Correction to Synthesis of 11 C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [ 11 C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof
Published in Journal of medicinal chemistry (09-05-2019)Get full text
Journal Article -
13
Correction to Synthesis of 11C‑Labeled RXR Partial Agonist 1‑[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [11C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof
Published in Journal of medicinal chemistry (09-05-2019)Get full text
Journal Article -
14
Teratogenicity and Fetal-Transfer Assessment of the Retinoid X Receptor Agonist Bexarotene
Published in ACS pharmacology & translational science (09-09-2022)“…Bexarotene, a retinoid X receptor (RXR) agonist, is used to treat cutaneous T-cell lymphoma, and drug repositioning research has also been reported, despite…”
Get full text
Journal Article -
15
Synthesis of 11 C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [ 11 C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof
Published in Journal of medicinal chemistry (24-08-2017)“…The retinoid X receptor (RXR) partial agonist 1-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic acid (1; CBt-PMN, E…”
Get full text
Journal Article -
16
A Novel 89 Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): "Lactosome" Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy
Published in Life (Basel, Switzerland) (18-02-2021)“…"Theranostics," a new concept of medical advances featuring a fusion of therapeutic and diagnostic systems, provides promising prospects in personalized…”
Get full text
Journal Article